Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-03-10 @ 7:23 PM
Study NCT ID:
NCT03138356
Status:
COMPLETED
Last Update Posted:
2017-12-07
First Post:
2017-04-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-25
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-21
First Submit QC Date:
None
Study First Post Date:
2017-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-06
Last Update Post Date:
2017-12-07
Last Update Post Date Type:
ACTUAL